Granules-Omnichem, a joint venture of Granules India Ltd and Belgium-based Ajinomoto Omnichem, will be setting up a set up a high value active pharmaceutical ingredients (APIs) and intermediates manufacturing facility in Visakhapatnam, a top official said. The USD 20-million-facility will start production by 2013 and earn revenues from 2015, Granules India Managing Director Krishna Prasad said. The JV will value through a unique contract manufacturing platform that will benefit through Ganules technological capabilities and OmniChem's extensive product portfolio and existing customers, he said. "The partnership will allow Granules, from day one, to focus on leveraging our core competency, which is offering high quality products and exemplary customer support with industry leading efficiency. In addition, Granules will have an opportunity to manufacture formulations for the JV APIs," he added. According to Gwin Bompas, Managing Director, Ajinomoto OmniChem, the JV's plant capacity will be utilized initially with OmniChem's extensive product portfolio and existing customers. The company will initially focus on high-value, low- volume APIs and intermediates for existing customers and will custom manufacture new chemical entities in the future.